Supplemental Figure 3b from Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia

Alexey V. Danilov,Charles Herbaux,Harriet S. Walter,Peter Hillmen,Simon A. Rule,Ebenezer A. Kio,Lionel Karlin,Martin J.S. Dyer,Siddhartha S. Mitra,Ping Cheng Yi,Rita Humeniuk,Xi Huang,Ziqian Zhou,Pankaj Bhargava,Juliane M. Jürgensmeier,Christopher D. Fegan

crossref（2023）

引用 0|浏览6

暂无评分

摘要

Supplemental Figure 3. Mean (SD) TIRA plasma concentration. Cycle 1 Day 8 data are shown in patients receiving TIRA monotherapy with A) TIRA/IDELA, and B) TIRA/ENTO*

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要